Septerna Inc $SEPN

Recent News (5)

• Septerna SVP Daniel Long sells $126,077 in company stock Investing.com · 04 Sep 2026 Septerna SVP Daniel Long sells $126,077 in company stock
• Septerna to Participate in Upcoming Investor Conferences GlobeNewswire · 01 Sep 2026 SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug d…
• Septerna appoints Rajiv Patni as chief medical officer Investing.com · 25 Aug 2026 Septerna appoints Rajiv Patni as chief medical officer
• Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer GlobeNewswire · 25 Aug 2026 SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug di…
• Septerna president & COO Elizabeth Bhatt disposes of $1.1m in stock Investing.com · 13 Aug 2026 Septerna president & COO Elizabeth Bhatt disposes of $1.1m in stock